首页 | 本学科首页   官方微博 | 高级检索  
     

癌性腹水的抗血管生成基因治疗研究
引用本文:赵霞,彭芝兰,赵敏,杨莉,魏于全. 癌性腹水的抗血管生成基因治疗研究[J]. 中国现代医学杂志, 2003, 13(7): 4-6
作者姓名:赵霞  彭芝兰  赵敏  杨莉  魏于全
作者单位:1. 四川大学华西第二医院妇产科,成都,610041
2. 四川大学华西医院,人类疾病生物治疗教育部重点实验室,610041
基金项目:国家自然科学基金资助 (3 0 0 70 2 94,3 0 0 70 83 5 )
摘    要:目的:探讨内皮抑素基因治疗在癌性腹水中的治疗作用。方法:在两个不同的小鼠肿瘤腹水模型腹腔内注射腺病毒载体介导的内皮抑素基因,观察其对腹水形成、腹膜的渗透性、肿瘤细胞的作用,以及对小鼠生存期的影响等。结果:用内皮抑素治疗组小鼠的腹水、腹膜的渗透性受到明显抑制,腹水中肿瘤细胞数明显减少,小鼠的生存期明显延长。结论:内皮抑素基因治疗有可能成为一种新的癌性腹水的治疗方法。

关 键 词:基因治疗 内皮抑素 腹水
修稿时间:2003-02-11

THERAPUTIC EFFECTS OF ADENOVIRAL VECTOR-MEDIATED ENDOS TATIN GENE TRANSFER IN MALIGNANT ASCITES
Zhao Xia,Peng Zilan,Zhao Ming,et al.. THERAPUTIC EFFECTS OF ADENOVIRAL VECTOR-MEDIATED ENDOS TATIN GENE TRANSFER IN MALIGNANT ASCITES[J]. China Journal of Modern Medicine, 2003, 13(7): 4-6
Authors:Zhao Xia  Peng Zilan  Zhao Ming  et al.
Affiliation:Zhao Xia,Peng Zilan,Zhao Ming,et al.Department of Gynecology and Obstetrics,The Second Affiliate Hospital,West China Medical School,Sichuan University,Chengdu 610041
Abstract:Objective:To evaluate the effects of endostatin adenoviral vector on malignant ascites.Methods: We constructed and administered adenovirial vectorencoding endostatin intraperitoneally in mice with malignant ascites . Results:Our data demostrated statistically significant downregulation of ascites formation and permeability of the microvessels lining peritoneal cavity and prolongation of animal survival after intraperitoneal treatment with endostatin adenoviral vector in two different ascites tumor models.Conclusions: These data suggest that adenoviral vector-mediated delivery of genes encoding endostatin may represent a potentially new treament for malignant ascites.
Keywords:Genetherapy  Endostatin  Ascites
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号